Country Sector Summary - November 2018
The Russian drug market ranks 14th globally, according to a Deloitte report on Russian Pharmaceutical Market Trends in 2018. The commercial market represents 73% in value and 85% in volume, with the government procurement market (secured with state money either through reimbursable drug coverage or hospital purchases) constitutes the rest. The global market is comprised of 64% of generics and of 36% of original drugs in value terms (2017, DSM), respectively 88% and 12% in volume. Prescription drugs represent 64% in value, but only 43% in terms of volume. In the state procurement segment alone, they represent 94% in money terms. In pharmacy chains, they constitute 50% of sales in value and 32% in volume.